Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • PSA flare in metastatic castra...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
PSA flare in metastatic castration-resistant prostate cancer patients treated with abiraterone or docetaxel

PSA flare in metastatic castration-resistant prostate cancer patients treated with abiraterone or docetaxel

Bibliographic Details
Main Authors: Hui-Ying Liu, Yuan-Chi Shen, Cheng-Jen Yu, Po-Hui Chiang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-06-01
Series:Urological Science
Online Access:http://www.sciencedirect.com/science/article/pii/S1879522616302184
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1879522616302184

Similar Items

  • Withdrawal syndrome and PSA flare in the management of mCRPC with abiraterone
    by: Po Hui Chiang
    Published: (2015-12-01)
  • PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
    by: España S, et al.
    Published: (2020-10-01)
  • Could ketoconazole predict the response of abiraterone in patients with metastatic castration-resistant prostate cancer (crpc) pre-treated with docetaxel
    by: Bo-Han Chen, et al.
    Published: (2015-06-01)
  • Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    by: Mostaghel EA
    Published: (2014-01-01)
  • Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
    by: Jian-Ri Li, et al.
    Published: (2017-11-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...